K/D Diet

K/D Diet Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 21 adverse event reports referencing K/D Diet, including 2 reports in which the animal died — a 950.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: K/D Diet. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in K/D Diet reports are Cat (12 reports), Dog (9 reports), with Cat accounting for the largest share. Within those species, Domestic Shorthair (7), Siamese (2), Retriever - Labrador (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with K/D Diet are Decreased appetite (4), Lethargy (see also Central nervous system depression in Neurological) (3), Diarrhoea (3), Weakness (3). Of the 21 reports with a coded outcome, Ongoing is the leading category at 52.4%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on K/D Diet.